ixazomib or lenalidomide post-asct in ndmm
Published 4 years ago • 110 plays • Length 4:20
Download video MP4
Download video MP3
Similar videos
-
1:24
mm-6 study: in-class transition to a regimen of ixazomib, lenalidomide, & dexamethasone for myeloma
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
4:28
lenalidomide and ixazomib: a successful amyloidosis treatment combination?
-
1:26
evaluating the efficacy of ixazomib, cyclophosphamide and dexamethasone in amyloidosis
-
1:49
real world data of ixazomib in combination with lenalidomide and dexamethasome
-
2:54
tourmaline-mm4: oral ixazomib maintenance for myeloma
-
0:58
the efficacy of ixazomib for the treatment of r/r myeloma
-
11:40
all about ninlaro (ixazomib)
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
2:21
mezigdomide: a novel celmod showing promise in the treatment of r/r myeloma
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
0:50
the safety and efficacy of isatuximab, bortezomib, lenalidomide, and dexamethasone in ndmm
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
1:51
how to manage tumor flare after administration of bispecific antibodies
-
5:45
ixazomib-based therapy for r/r myeloma in the real-world setting
-
3:11
drammatic: dara & len for maintenance post-asct in myeloma
-
1:19
insights into a phase i/ia study of venetoclax, ixazomib and dexamethasone for r/r al amyloidosis
-
2:04
isatuximab, carfilzomib, lenalidomide, and dexamethasone in multiple myeloma: the skylark trial
-
1:09
an update on alliance a061202: addition of ixazomib to pomalidomide-dexamethasone in r/r myeloma
-
1:55
the real-world efficacy of brentuximab vedotin consolidation post-autosct in r/r hl
-
5:54
addressing the risk of cancer after aav vector dosing in patients with hemophilia
-
1:44
prevention of progression: ixazomib/len/dex in high-risk smm
Clip.africa.com - Privacy-policy